Collegium Pharmaceutical, Inc.COLLNASDAQ
Loading
EBITDA Margin Over TimeExpanding
Percentile Rank100
3Y CAGR+27.2%
5Y CAGR+15.1%
Year-over-Year Change
EBITDA as a percentage of revenue
3Y CAGR
+27.2%/yr
vs +3.3%/yr prior
5Y CAGR
+15.1%/yr
Recent acceleration
Acceleration
+23.9pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
2x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | 76.85% | +42.0% |
| 2024 | 54.11% | -0.5% |
| 2023 | 54.40% | +45.6% |
| 2022 | 37.36% | +19.5% |
| 2021 | 31.26% | -17.9% |
| 2020 | 38.07% | +1884.3% |
| 2019 | -2.13% | -106.5% |
| 2018 | 32.78% | +112.6% |
| 2017 | -260.82% | +95.2% |
| 2016 | -5460.37% | - |